Phase 2 GLEAM Trial of Zolbetuximab in Pancreatic Cancer Falls Short of Primary Endpoint

Astellas Pharma Inc. has announced that its Phase 2 GLEAM trial evaluating zolbetuximab in combination with gemcitabine plus nab-paclitaxel for metastatic pancreatic adenocarcinoma did not meet its primary endpoint of…

Continue Reading Phase 2 GLEAM Trial of Zolbetuximab in Pancreatic Cancer Falls Short of Primary Endpoint

Navigating the Challenges of Biomarker Testing in Oncology: Innovations for Low-Yield Samples

Biomarker analysis plays a pivotal role in cancer care and research, guiding the development of targeted therapies and enabling personalized treatment plans. While next-generation sequencing (NGS) has revolutionized the ability…

Continue Reading Navigating the Challenges of Biomarker Testing in Oncology: Innovations for Low-Yield Samples

Datroway Shows Survival Benefit in Late-Stage Trial for Triple-Negative Breast Cancer

AstraZeneca and Daiichi Sankyo have announced promising Phase 3 trial results for Datroway, their investigational antibody-drug conjugate (ADC) targeting triple-negative breast cancer (TNBC). The trial demonstrated that Datroway significantly slowed…

Continue Reading Datroway Shows Survival Benefit in Late-Stage Trial for Triple-Negative Breast Cancer

Finding Strength in Connection: How Breast Cancer Support Communities Are Transforming Patient Care

When a woman hears the words, “You have cancer,” her world shifts in an instant. The journey ahead—marked by treatment, uncertainty, and emotional upheaval—can feel isolating, even for the strongest…

Continue Reading Finding Strength in Connection: How Breast Cancer Support Communities Are Transforming Patient Care

Early Research on Two Tough Cancers

Pancreatic cancer took Alex Trebek, Michael Landon, Ruth Bader Ginsburg, Luciano Pavarotti, Steve Jobs,  Patrick Swayze, and my dear friend Amy. Glioblastoma (GBM) took Senators John McCain and Ted Kennedy,…

Continue Reading Early Research on Two Tough Cancers

The Unspoken Guilt of Living

Editor's Note: Patient Worthy is honored to share this story from our friends at Elephants & Tea. To see the article in its original form, please click here. Original author…

Continue Reading The Unspoken Guilt of Living

Dewpoint Therapeutics Secures Series D Funding to Pioneer Novel Gastric Cancer Therapy

Dewpoint Therapeutics, a U.S.-based biotechnology innovator, has announced the successful closure of its Series D financing round. As reported by thepharmaletter, Dewpoint Therapeutics is renowned for its pioneering work in…

Continue Reading Dewpoint Therapeutics Secures Series D Funding to Pioneer Novel Gastric Cancer Therapy